Filed in archive
Corporate and Industrial News
by ruth on September 28, 2005

Generex Biotechnology Corporation hosted a press conference yesterday afternoon at its Toronto offices to provide the European press with an overview of the Company and its proprietary buccal drug delivery platform technologies, particularly the status of the clinical and regulatory global development program for Oralin, its proprietary oral insulin buccal spray for the treatment of both type 1 and type 2 diabetes.
A webcast of the press conference is available here. To dial in and listen to the webcast please call 1-706-643-7496 .
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9813
Mr Wong
Vote for Generex Webcast Regarding Oralin Launch In Ecuador:
|
Rating: 7.60 out of 10 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







